transcriptomics Jun 22, 2022 Agendia Building Validation Data on ImPrint for Guiding Neoadjuvant Immunotherapy in Breast Cancer Premium May 20, 2022 MSK Starts Offering Pediatric Cancer Patients Whole-Genome, Transcriptome Sequencing Premium Apr 11, 2022 Cancer Genomics Project in Southwestern American Indians Aims to Improve Research, Care Disparities Apr 7, 2022 Pangea Biomed Builds on RNA-Based Drug Matching to Expand Precision Oncology Opportunities Premium Mar 29, 2022 Zentalis Pharmaceuticals, Caris Life Sciences Ink Precision Oncology Partnership Mar 10, 2022 Novigenix, Philips Ink Technology License Agreement for Prostate Cancer Tests Oct 13, 2021 Mayo Clinic, Personalis Ink Comprehensive Genomics Research Collaboration Oct 12, 2021 BostonGene Helping MassGeneral Improve Understanding of Follicular Lymphoma Progression, Treatment Aug 19, 2021 Mounting Research Backs MHC as Immune Checkpoint Inhibitor Biomarker Premium Aug 11, 2021 Sema4, Avera Health Collaborate on Precision Oncology Program May 7, 2021 Breast Cancer Immunotherapy Response Markers Emerge From Single-Cell Sequencing Study Apr 30, 2021 Transcriptomic Algorithm Shows Ability to Predict Progression-Free Survival in Cancer Patients Premium Apr 27, 2021 BostonGene, Medical College of Wisconsin Partner on Pancreatic Cancer Biomarker Research Apr 7, 2021 OncoDNA, myNEO Partner to Advance Bespoke mRNA-Based Cancer Vaccines Mar 23, 2021 Caris-Led Team Searches for Clues to Poor COVID-19 Outcomes in Cancer Patients' Transcriptome Data Premium Feb 4, 2021 Veracyte to Use Decipher Biosciences Acquisition to Expand Commercial Cancer Testing Reach Premium Jan 22, 2021 Caris Shares Data for AI-Driven Tumor Origin Prediction, Hinting at Diagnostic, Patient Benefit Premium Dec 22, 2020 Agendia FLEX Registry Powers Genomics Research on Underrepresented Breast Cancer Patients Premium Nov 10, 2020 BostonGene, Thomas Jefferson University Partner on Head, Neck Cancer Research Oct 27, 2020 Caris Life Sciences Raises $310M Through Equity, Debt Financing Load More Breaking News FDA Approves Taiho Oncology's Lytgobi for FGFR2-Rearranged Bile Duct Cancer Gladstone Institute Joins With Parker Institute on New Center to Study CRISPR-Based Cell Therapies Meliora Therapeutics Raises $11M in Seed Financing In Brief This Week:Â Verismo Therapeutics, Fore Biotherapeutics, Merck, Caris Life Sciences Tumor-Only Sequencing Found to Overestimate Mutational Burden in Non-European Patients Atara Biotherapeutics to Net $30M From Pierre Fabre for European Tab-Cel Approval
